Adaptimmune Therapeutics
ADAP
#9244
Rank
NZ$0.12 B
Marketcap
$0.46
Share price
3.09%
Change (1 day)
-76.33%
Change (1 year)

P/S ratio for Adaptimmune Therapeutics (ADAP)

P/S ratio as of April 2025 (TTM): 0.4065

According to Adaptimmune Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.11. At the end of 2024 the company had a P/S ratio of 0.8480.

P/S ratio history for Adaptimmune Therapeutics from 2016 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20240.8480-71.62%
20232.99-66.09%
20228.81-90.75%
202195.3-54.81%
202021187.41%
20191121013.07%
201810.1-38.91%
201716.5-18.08%
201620.2

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.68 314.09%๐Ÿ‡บ๐Ÿ‡ธ USA
0.5652 39.04%๐Ÿ‡บ๐Ÿ‡ธ USA
33.4 8,128.07%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
4.85 1,093.18%๐Ÿ‡บ๐Ÿ‡ธ USA